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Abstract: Mycoplasma genitalium is an emerging sexu-
ally transmitted pathogen implicated in urethritis in men
and several inflammatory reproductive tract syndromes
in women including cervicitis, pelvic inflammatory
disease (PID), and infertility. This comprehensive review
critically examines epidemiologic studies of M. genitalium
infections in women with the goal of assessing the
associations with reproductive tract disease and enhanc-
ing awareness of this emerging pathogen. Over 27,000
women from 48 published reports have been screened
for M. genitalium urogenital infection in high- or low-risk
populations worldwide with an overall prevalence of
7.3% and 2.0%, respectively. M. genitalium was present in
the general population at rates between those of
Chlamydia trachomatis and Neisseria gonorrhoeae.C o n -
sidering more than 20 studies of lower tract inflamma-
tion, M. genitalium has been positively associated with
urethritis, vaginal discharge, and microscopic signs of
cervicitis and/or mucopurulent cervical discharge in
seven of 14 studies. A consistent case definition of
cervicitis is lacking and will be required for comprehen-
sive understanding of these associations. Importantly,
evidence for M. genitalium PID and infertility are quite
convincing and indicate that a significant proportion of
upper tract inflammation may be attributed to this
elusive pathogen. Collectively, M. genitalium is highly
prevalent in high- and low-risk populations, and should
be considered an etiologic agent of select reproductive
tract disease syndromes in women.
Introduction
An estimated 340 million new curable cases of sexually
transmitted infections (STIs) are acquired annually throughout
the world [1], making these infections an important public
health and economic concern. Mycoplasma genitalium is an
emerging cause of STIs in the United States [2] and has been
implicated in urogenital infections of men and women around
the world. More than 25 years after its initial isolation from men
with non-gonococcal urethritis (NGU; [3]), M. genitalium is now
recognized as an independent etiologic agent of acute and
persistent male NGU and is responsible for approximately
20%–35% of non-chlamydial NGU cases [4,5]. Implicating this
organism in male urogenital disease was a significant advance-
ment in our knowledge of STIs, but it has been less clear
whether M. genitalium is also a cause of inflammatory
reproductive tract disease in women. This comprehensive
literature review (PubMed database; MeSH ‘‘Mycoplasma
genitalium’’ with no restrictions on publication year) addresses
the overall population prevalence and associations of M.
genitalium with inflammatory syndromes of the female reproduc-
tive tract.
Epidemiology and Prevalence of M. genitalium
Infections
After the initial isolation in 1980 [3], few epidemiologic studies
of M. genitalium infection were undertaken largely because of
difficulties in cultivation of this fastidious organism. Some 10 years
later, the polymerase chain reaction (PCR) was first employed for
detection of M. genitalium in patient specimens [6,7], thereby
facilitating larger investigations of prevalence and associations with
urogenital disease. Using such molecular methods, sexual
transmission of the organism has been suggested by high
concordance rates among sexual partners [8–15] and documented
specifically in infected couples with concordant M. genitalium
genotypes [11,15]. In addition, sexual transmission of M. genitalium
infection can be inferred from increased prevalence values in
cohorts reporting sexual intercourse and the association with
number of sex partners [2,16]. For the purpose of this review,
high-risk individuals were defined as those attending an STI clinic,
those enrolled in a study where inclusion criteria included signs of
urogenital disease, patients presenting to family planning clinics
for termination of pregnancy, or those individuals classified as sex
workers. Low-risk enrollees were those not attending an STI clinic,
fertility clinic attendees, those chosen randomly from an otherwise
healthy population, and all women enrolled in studies of adverse
pregnancy outcomes.
Considering 27,272 women from 40 independent studies,
among women from low-risk populations (n=8,434; [2,14,16–
24]), the prevalence of M. genitalium infection was 2.0% with most
cohorts between ,1%–5% (Table S1). In three studies of low-risk
individuals where enrollees were randomly selected from commu-
nity or population-based survey populations ([2,16,19]; n=4,075),
the prevalence was also 2%. Among these was the US National
Longitudinal Study of Adolescent Health, which showed the
genital prevalence of M. genitalium to be approximately 1%,
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(4.2%), respectively [2]. Thus, M. genitalium prevalence in the
general population is on par with other sexually transmitted
pathogens of significant public health concern.
Using the above definition of high-risk populations, 18,838
women have been tested for M. genitalium urogenital infection [6–
8,10,13,25–56]with a substantially higher prevalence than low-risk
groups (7.3%; Table S1). Among studies of high-risk individuals,
the population prevalence values ranged from 0% to 42% and can
be explained by several factors, including the clinical setting,
specificity of the employed NAAT assay, participant enrollment
criteria (e.g., specific symptoms or signs), geographic location of
study site, high-risk behavior (e.g., commercial sex workers), co-
infection with other STIs, and the reporting of point or
cumulative, multi-sampling values. Importantly, we considered
only point prevalence values in the overall prevalence calculations
because cumulative, multi-sampling values were not directly
comparable. In conclusion, considering sexual transmission and
the high prevalence worldwide, the public health significance of
M. genitalium infections in women is potentially very large.
Clinical Correlates with Lower Urogenital Tract
Inflammation in Women
Vaginal Discharge
In more than 20 independent clinical studies, M. genitalium has
been evaluated as a cause of inflammatory lower genital tract
syndromes including urethritis, cervicitis, and vaginal discharge.
From 2002 to 2010, six studies addressed the relationship between
M. genitalium infection and vaginal discharge (n=3,059; Table 1)
with significant associations observed in three [14,43,51]. Vaginal
discharge was measured either as a symptom or sign among the
cited studies and the criteria varied from any sign of discharge to
defined pathologic symptoms such as discharge characterized as
heavy, yellow, or green-gray with mucous-like or creamy
consistency (see Table 1 for specific diagnostic criteria for each
study). No clear trend was evident as to whether signs or symptoms
were better predictors of M. genitalium infection, as only two studies
used vaginal symptoms in their diagnostic criteria.
Etiologies of vaginal discharge are extremely diverse, can be
either microbial or non-microbial, may be normal or abnormal,
and can be attributed to inflammation in other parts of the
reproductive tract (reviewed in [57]). Only one study adjusted for
the presence of bacterial vaginosis (BV; [43]) and, despite a high
rate of BV in the cohort, demonstrated significant associations of
M. genitalium with vaginal discharge. However, evaluation of a
similar population 4 years later did not reproduce the finding [13].
Further, the case definition of pathologic discharge was variable
between studies and, most importantly, patient-reported symptoms
are a highly subjective measure. Therefore, the disparity among
studies is not surprising. Future studies with defined and/or
quantitative signs that control for co-infection with other STIs and
concurrent inflammatory syndromes (e.g., bacterial vaginosis) will
be necessary to determine whether M. genitalium is independently
associated with vaginal discharge.
Urethritis
Considering only microscopic signs of urethral inflammation
(.4–5 or .10 polymorphonuclear leukocytes per high-powered
microscope field [PMNL/hpf]), positive associations with M.
genitalium infection were found in three of four studies [8,40,49].
One study, the largest of Scandinavian women ([49]; n=7,604;
Table 1), found a significant association between M. genitalium and
microscopic urethritis. Three other Scandinavian studies of
urethritis failed to show a significant association with M. genitalium
infection even when patients co-infected with C. trachomatis [10]
were removed or after adjusting for concurrent cervicitis [8,9].
However, Anagrius and colleagues showed a significant association
with microscopic signs of urethritis and/or cervicitis in Swedish
women [8]. This study exemplifies that exclusion of women with
concurrent cervicitis or other inflammatory syndromes is impor-
tant because inflammation from other sites may contaminate the
urethra leading to a false diagnosis of urethritis. Two of the studies
that failed to show a significant association between M. genitalium
and urethritis, but did control for concurrent cervicitis [8,40],
showed a strong trend towards association with lower bounds of
their respective 95% CIs close to the null. Importantly, M.
genitalium is a recognized cause of sexually acquired acute and
persistent urethritis [4,5] in men. However, considering the
disparate results of the cited studies, we cannot conclusively
implicate M. genitalium as a cause of female urethritis. Additional
investigations of M. genitalium urethritis are warranted, especially in
populations outside of Scandinavia.
Cervicitis
Cervicitis, often termed mucopurulent cervicitis [58], is
characterized by the presence of clinical signs such as mucopu-
rulent discharge, friability at the external os (easily induced
bleeding), elevated counts of PMNL detected by Gram staining of
endocervical swab material, or a combination of these signs [58].
However, there is no generally accepted case definition of
cervicitis. Among epidemiologic studies of cervicitis in high- and
low-risk populations (Table 2; n=13,000 women), M. genitalium has
been positively associated with cervical inflammation in all studies
where microscopic signs were considered independent of non-
microscopic signs [8,10,30,40,47,49]. Of these, only two studies
showed significant correlations [10,49]. Considering non-micro-
scopic criteria (see study by Pepin et al. [51] for diversity of non-
microscopic signs), cervical discharge was the most consistently
measured among the retained studies. Four of eight studies showed
positive associations between cervical discharge and M. genitalium
infection, all of which were significant relative to women without
this sign (Table 2; [25,36,47,51]).
Two studies have addressed whether microscopic or non-
microscopic signs are better predictors of M. genitalium cervicitis
within the same patient population. Casin et al. found no
significant associations using either cervical discharge or micro-
scopic signs (.10 pmn/hpf) [30], but all women in this study had
vaginal discharge. However, Manhart and colleagues found no
significant association between M. genitalium infection and cervicitis
defined by .30 PMNL/hpf, but statistical significance was
observed with abnormal cervical discharge ([47]; Table 2).
Further, considering all studies of M. genitalium cervicitis, those
where a high threshold of microscopic cervicitis (.20 or .30
PMNL/hpf, or more PMNL than epithelial cells) was employed,
only three of seven studies showed a significant correlation
between microscopic signs and M. genitalium infection ([10,46,49];
Table 2). This suggests that a high microscopic threshold of
inflammation is not a more specific sign of M. genitalium cervicitis
and might also fail to detect less severe inflammation. Collectively,
it is clear that discrepancies among these studies can be attributed
to the variable case definition of cervicitis and studies with uniform
criteria will be required to address which sign(s) best predict M.
genitalium cervicitis.
C. trachomatis is a common cause of cervicitis and a potentially
confounding variable for implicating M. genitalium as an indepen-
dent etiologic agent. Where possible, we excluded subjects with C.
trachomatis co-infection for all OR calculations (see Table 2). Six of

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































PLoS Pathogens | www.plospathogens.org 4 May 2011 | Volume 7 | Issue 5 | e1001324nine studies where C. trachomatis co-infection was either excluded
or adjusted for in multivariate analyses found significant
associations between M. genitalium and cervicitis [10,25,36,
46,49,51], whereas only a single study [47] showed significant
associations without this adjustment. Studies controlling for N.
gonorrhoeae infection are lacking. Despite these differences, several
clinical investigations of urogenital disease in women indeed
indicate that M. genitalium should be considered an independent
risk factor for cervicitis, particularly when urogenital specimens
are negative for other known pathogens. Importantly, this
magnitude of increased risk is similar to those of other known
causes of cervicitis, including C. trachomatis and N. gonorrhoeae [46].
Upper Reproductive Tract Infection by M.
genitalium
Pelvic Inflammatory Disease
Following sexual transmission, cervical passage of M. genitalium
could result in ascending infection of the endometrium or further
to the fallopian tubes leading to tubal inflammation and infertility.
M. genitalium was first suspected as a cause of pelvic inflammatory
disease (PID) in 1984 [59]. Since, five PCR-based studies have
found a positive association of M. genitalium with clinical PID from
geographically diverse populations around the world ([27,31,
39,54,56]; Table 3). In the first of these, of 58 Kenyan women with
histologically confirmed endometritis, M. genitalium was found
significantly more often in women with endometritis compared to
women without this condition (16% versus 2%; [31]). Similarly, in
a sub-study from the US PID Evaluation of Clinical Health
cohort, women with M. genitalium were three times more likely to
have endometritis at enrollment compared to women without M.
genitalium [39].
In two cross-sectional studies where the endometrium was
sampled directly to measure the associations of current infection
and upper tract disease [31,33,39], M. genitalium was associated
significantly with endometritis [31,39]. In contrast, one prospec-
tive study of commercial sex workers in Kenya failed to find an
association of M. genitalium infection with PID [33] over 36
months. Considering the persistent nature of M. genitalium, as with
other STIs, it is possible that the follow-up period and high
percentage of loss to follow-up was not adequate to detect incident
PID. Importantly, clinical diagnosis of PID includes several
variable signs (see Table 3) that often do not correlate with
laparoscopic findings [54]; this undoubtedly contributes to
variability among PID studies and could impact the associations
with M. genitalium infection. Further, no clear trend was observed
when comparing studies that removed co-infections with C.
trachomatis or controlled for co-infections in multivariate analyses.
Overall, M. genitalium has been associated with microscopic
endometritis and PID, and confirmatory studies are clearly
necessary to establish an independent role and investigate the
mechanisms for upper reproductive tract inflammation.
Pregnancy-Related Complications and Infertility
PID can be a pre-cursor to several significant upper tract
complications, including ectopic pregnancy, chronic pelvic pain
and tubal factor infertility [60]. No association between M.
genitalium and ectopic pregnancy was observed in a single study
using serological testing for M. genitalium exposure ([42]; Table 4).
Considering other adverse pregnancy outcomes including preterm
birth, spontaneous abortion or miscarriage, stillbirth, and small for
gestational age, of five independent studies ([20,21,42,44,53];






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































PLoS Pathogens | www.plospathogens.org 7 May 2011 | Volume 7 | Issue 5 | e1001324association of M. genitalium with preterm birth [18,20], but no
other syndromes have been linked to this infection.
In contrast, investigations into M. genitalium as a cause of
infertility have consistently shown a strong correlation. Two
Danish studies have found a significant association between
women with M. genitalium–specific serum antibodies and laparo-
scopically confirmed tubal infertility ([17,24]; Table 4). Exclusion
of women with prior C. trachomatis infection still resulted in
significant association between M. genitalium and infertility ([24];
Table 4). In one study, PCR detection of M. genitalium was
attempted from endocervical swabs with no success, suggesting
that previous M. genitalium infection might cause permanent
damage to the oviduct, or that endocervical swabs are ineffective
for detecting upper genital tract infection. However, in a recent
study of Polish women by Grzesko and colleagues, M. genitalium
was detected by PCR more often in cervical swabs from infertile
patients compared to healthy, fertile women [37], suggesting that
endocervical swabs can predict upper tract infection. It is
important to note that NAAT studies make associations between
current infection and infertility, while serological studies determine
associations with prior M. genitalium exposure. Because tubal
scarring can result in long-term infertility, serological studies
probably best address whether M. genitalium is a cause of tubal-
factor infertility and can be useful in determining recent or long-
term infections (e.g., IgM versus IgG antibodies).
Experimental animal models have also provided evidence that
M. genitalium can colonize upper reproductive tract tissues, leading
to salpingitis or endometritis [61–63]. Thus, it is evident that M.
genitalium could be an independent cause of tubal factor infertility.
Importantly, however, the few studies to date have been relatively
small in size and longitudinal studies would be of tremendous
benefit for understanding this complex condition whereby prior
infection can lead to long-term sequelae.
Recommended Treatment of M. genitalium and
Important Considerations
Evaluation of M. genitalium treatment efficacy has been a subject
of obvious importance but conclusive recommendations are
lacking largely because, to date, only a single randomized
controlled clinical trial has been reported [64]. In this trial, a
single 1-g dose of azithromycin was more effective than 7-day,
multi-dose doxycycline for eradication of M. genitalium infection in
men. In patients diagnosed with PID, the US Centers for Disease
Control and Prevention guidelines recommend therapy with
ceftriaxone plus doxycycline or cefoxitin and probenecid plus
doxycycline [65]. These treatments are primarily targeted towards
C. trachomatis and N. gonorrhoeae, to which less than half of PID cases
can be attributed [66]. Importantly, several reports suggest these
treatment regimens would be ineffective for eradicating M.
genitalium, as male and female genital infections persist in a
significant proportion of patients treated with tetracyclines [67–71]
or levofloxacin [68,72].
Using azithromycin (1 g; single dose), clinical cure rates are only
between 79% and 87% for M. genitalium–positive male and female
patients, leaving a significant subset of patients with persistent
urogenital tract infections [29,64,67,73]. Extended 5-day regimens
of azithromycin therapy increase cure rates to 96% after
doxycycline treatment failure [67], and additional randomized
trials are now required to determine the optimum dosage and
regimen. If patients fail extended azithromycin therapy, moxi-
floxacin is the only available antibiotic with a successful rate of
cure [73] and should be used only with patients failing other
therapies. Successful treatment of M. genitalium infection in female
patients is of particular importance because prolonged inflamma-
tion at upper genital tract sites might lead to significant
reproductive tract morbidity and infertility [74]. In women,
treatment must be effective for both lower and upper genital tract
infection.
Conclusions and Implications for Future Research
Following the firm establishment that M. genitalium causes NGU
in men and is a cause of STI, many studies have now found
significant associations with lower and upper reproductive tract
disease in women. Taken together, M. genitalium should be
considered an etiologic agent of cervical inflammation and upper
tract disease syndromes, including PID and infertility. Important-
ly, additional studies with defined diagnostic criteria will be
required to fully understand the relationship between M. genitalium
and cervicitis. A systematic review and meta-analysis would be of
significant benefit for defining the associations of M. genitalium
infection with reproductive tract disease in women.
Although not addressed in this review, M. genitalium likely
maintains persistent infection through intracellular survival in
mucosal epithelial cells [75,76] resulting in inflammation [75,77].
The observed correlations between M. genitalium reproductive tract
infection and HIV-1 (reviewed in [78]) may be explained by long-
term inflammation elicited by M. genitalium infection; these
associations are likely of particular importance considering the
enormous public health burden of HIV infections worldwide.
Therefore, continued research will be important to understand the
dynamics of persistent HIV-1 and M. genitalium co-infections of
vaginal and cervical tissues, particularly when dissecting clinical
correlates with disease.
We still have much to learn about reproductive tract infections
from both a clinical and basic science standpoint. Overall, M.
genitalium appears to be a highly prevalent sexually transmitted
bacterial pathogen that, if not diagnosed and the patient treated
appropriately, can cause persistent urogenital inflammation in
men and women and increase the risk of HIV transmission and
infection. Continued investigation of M. genitalium’s role in sexually
transmitted disease will be pivotal for understanding the complex
and dynamic inflammatory syndromes of the female reproductive
tract.
Supporting Information
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